| 1 |
Brouillard M, Kinet R, Joyeux M, Dehay B, Crauste-Manciet S, Desvergnes V. Modulating Lysosomal pH through Innovative Multimerized Succinic Acid-Based Nucleolipid Derivatives. Bioconjug Chem 2023;34:572-80. [PMID: 36853958 DOI: 10.1021/acs.bioconjchem.3c00041] [Reference Citation Analysis]
|
| 2 |
Chroni A, Mavromoustakos T, Pispas S. Curcumin-Loaded PnBA-b-POEGA Nanoformulations: A Study of Drug-Polymer Interactions and Release Behavior. Int J Mol Sci 2023;24. [PMID: 36902057 DOI: 10.3390/ijms24054621] [Reference Citation Analysis]
|
| 3 |
Scognamiglio PL, Riccardi C, Palumbo R, Gale TF, Musumeci D, Roviello GN. Self-assembly of thyminyl l-tryptophanamide (TrpT) building blocks for the potential development of drug delivery nanosystems. J Nanostruct Chem 2023. [DOI: 10.1007/s40097-023-00523-7] [Reference Citation Analysis]
|
| 4 |
Calero M, Moleiro LH, Sayd A, Dorca Y, Miquel-rio L, Paz V, Robledo-montaña J, Enciso E, Acción F, Herráez-aguilar D, Hellweg T, Sánchez L, Bortolozzi A, Leza JC, García-bueno B, Monroy F. Lipid nanoparticles for antisense oligonucleotide gene interference into brain border-associated macrophages. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.887678] [Reference Citation Analysis]
|
| 5 |
Riccardi C, D’aria F, Fasano D, Digilio FA, Carillo MR, Amato J, De Rosa L, Paladino S, Melone MAB, Montesarchio D, Giancola C. Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! IJMS 2022;23:12412. [DOI: 10.3390/ijms232012412] [Reference Citation Analysis]
|
| 6 |
Riccardi C, D'Aria F, Digilio FA, Carillo MR, Amato J, Fasano D, De Rosa L, Paladino S, Melone MAB, Montesarchio D, Giancola C. Fighting the Huntington's Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies. Int J Mol Sci 2022;23:4804. [PMID: 35563194 DOI: 10.3390/ijms23094804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM. Development of Peptide Biopharmaceuticals in Russia. Pharmaceutics 2022;14:716. [DOI: 10.3390/pharmaceutics14040716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Zingale E, Bonaccorso A, Carbone C, Musumeci T, Pignatello R. Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications. Pharmaceutics 2022;14:691. [PMID: 35456525 DOI: 10.3390/pharmaceutics14040691] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Nikitina M, Bragina E, Nazarenko M, Alifirova V. The role of alleles with an intermediate number of trinucleotide repeats in Parkinson’s disease and other neurodegenerative disorders. Z nevrol psikhiatr im S S Korsakova 2022;122:42. [DOI: 10.17116/jnevro202212207142] [Reference Citation Analysis]
|
